Contend
发表于 2025-3-30 12:03:08
http://reply.papertrans.cn/23/2212/221125/221125_51.png
Blanch
发表于 2025-3-30 15:50:17
https://doi.org/10.1007/978-3-211-71489-8as combinational therapy, are explored. Since a clear concept of the pathobiology of NHL is necessary for efficient immunotherapy, a brief description with an emphasis on suitable targets for immunotherapy is given before discussing various immunotherapies.
平
发表于 2025-3-30 18:30:47
https://doi.org/10.1007/978-3-211-71489-8ng immunization in hepatocellular carcinoma. In this chapter we have reviewed the hepatobiliary tumors, the role of immunotherapy, and its relevant mechanisms to cancer therapy. In addition, some immunotherapeutic approaches are discussed.
反复拉紧
发表于 2025-3-31 00:04:57
http://reply.papertrans.cn/23/2212/221125/221125_54.png
最高点
发表于 2025-3-31 04:22:42
http://reply.papertrans.cn/23/2212/221125/221125_55.png
artless
发表于 2025-3-31 05:53:48
Hepatobiliary Tumors: Immunopathology and Immunotherapy,ng immunization in hepatocellular carcinoma. In this chapter we have reviewed the hepatobiliary tumors, the role of immunotherapy, and its relevant mechanisms to cancer therapy. In addition, some immunotherapeutic approaches are discussed.
残忍
发表于 2025-3-31 12:13:49
Immunopathology of Specific Cancers in Males and Females and Immunotherapy of Prostate and Cervical terms of increased mortality and morbidity. Here, it is aimed to review the clinical experiences and results achieved with immunotherapy for treating prostate and cervical cancers, two of the most significant malignancies in human males and females, respectively.
enumaerate
发表于 2025-3-31 14:33:06
https://doi.org/10.1007/978-3-030-32598-5ts, the results are promising even in patients with advanced disease and should be explored further. In this chapter, we review the different immunotherapeutic approaches that have been and are being evaluated in the pediatric oncology setting.
并排上下
发表于 2025-3-31 20:41:55
http://reply.papertrans.cn/23/2212/221125/221125_59.png
羊齿
发表于 2025-3-31 22:41:59
Film, the Narration of a World,s, and natural killer cells) and pathways (MAPK and NF-κB) and immune responses (T cells, B-cells, and dendritic cells) to the evaluation of emerging immunotherapeutic opportunities (immune checkpoint inhibitors, cytokine-based immunotherapies, vaccines, and biochemotherapy).